F&P: CPAP mask sales are tracking higher
By HME News Staff
Updated 10:06 AM CDT, Wed March 23, 2022
AUCKLAND, New Zealand – Fisher & Paykel expects full year operating revenue of $1.675 billion to $1.70 billion for its 2022 financial year, which ends March 31.
“Our second half hospital consumables revenue is currently tracking to be similar to the hospital consumables revenue that we reported in the first half of the 2022 financial year,” said Lewis Gradon, managing director and CEO. “This is consistent with reports of the increasing prevalence of the Omicron variant over the last two months and its associated lower respiratory intervention requirements, as well as a relatively mild flu season in the Northern Hemisphere.”
F&P says sales of CPAP masks are currently tracking above the first half of the year, despite continued supply constraints on CPAP devices.
The company says freight rates remain elevated and are expected to impact its long-term gross margin target of 65% by approximately 250 basis points for the 2022 financial year.
Fisher & Paykel previously reported total operating revenue of $900 million for the first six months of its 2022 financial year, which ended Sept. 30, 2021.
Comments